We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Gastroenterology

Gastroenterology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Unraveling the Diarrheal Outbreaks: Understanding Cyclospora and Cryptosporidiosis in the United States
GastroenterologyCryptosporidiosisCyclospora

Unraveling the Diarrheal Outbreaks: Understanding Cyclospora and Cryptosporidiosis in the United States

By MedXY|Jul 17, 2026

This article explores recent outbreaks of Cyclospora and Cryptosporidium infections in the U.S., their transmission, clinical features, diagnosis, treatment, and prevention, highlighting the public health impact and clinical challenges.

Polypharmacy Challenges in Older Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: Navigating Care in a High-Risk Population
Gastroenterologycardiometabolic diseasesMASLD

Polypharmacy Challenges in Older Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: Navigating Care in a High-Risk Population

By MedXY|Jul 17, 2026

Older adults with MASLD, especially those aged 75 and above, experience a high burden of polypharmacy linked to multimorbidity, necessitating careful medication management to balance disease control and geriatric vulnerabilities.

Timing Matters: Optimizing Additional Surgery after Noncurative Endoscopic Submucosal Dissection in Early Gastric Cancer
Gastroenterologyadditional surgery timingearly gastric cancer

Timing Matters: Optimizing Additional Surgery after Noncurative Endoscopic Submucosal Dissection in Early Gastric Cancer

By MedXY|Jul 17, 2026

Delaying additional surgery beyond 35 days after noncurative endoscopic submucosal dissection (ESD) in early gastric cancer reduces operative time and blood loss, potentially improving perioperative outcomes.

Robotic Versus Laparoscopic Complex Elective Cholecystectomy: Balancing Outcomes and Costs
GastroenterologyComplex gallbladder diseaseHealthcare Costs

Robotic Versus Laparoscopic Complex Elective Cholecystectomy: Balancing Outcomes and Costs

By MedXY|Jul 17, 2026

Robotic cholecystectomy for complex gallbladder disease reduces postoperative complications and interventions compared to laparoscopic surgery without increasing total costs, suggesting a strategic role for robotic platforms in complex case

Global Variability in Non-Invasive Testing Accuracy for MASLD: Key Findings from the G-MASLD Study
GastroenterologyGlobal studyliver fibrosis

Global Variability in Non-Invasive Testing Accuracy for MASLD: Key Findings from the G-MASLD Study

By MedXY|Jul 16, 2026

The G-MASLD study evaluated the diagnostic accuracy of non-invasive fibrosis tests across 41 countries, revealing regional variability and identifying Agile-3+ and Agile-4 as the most accurate for advanced fibrosis and cirrhosis in MASLD pa

Targeting SOX9-Driven SPEM Plasticity: A New Therapeutic Avenue to Prevent Gastric Cancer Progression
Gastroenterologycell plasticityGastric Cancer

Targeting SOX9-Driven SPEM Plasticity: A New Therapeutic Avenue to Prevent Gastric Cancer Progression

By MedXY|Jul 16, 2026

SOX9 is a pivotal regulator of SPEM cell plasticity driving gastric metaplasia and carcinogenesis. Therapeutically targeting SOX9 may prevent the progression of pre-cancerous lesions to gastric cancer by blocking metaplastic evolution.

Outcomes of Colorectal Dysplasia and Cancer in Patients with PSC-IBD Undergoing Liver Transplantation and Colectomy: Insights from a Multicenter Study
Gastroenterologycolorectal cancerinflammatory bowel disease

Outcomes of Colorectal Dysplasia and Cancer in Patients with PSC-IBD Undergoing Liver Transplantation and Colectomy: Insights from a Multicenter Study

By MedXY|Jul 15, 2026

This multicenter retrospective study examines colorectal dysplasia and malignancy outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease undergoing liver transplantation and colectomy, revealing comparable 5

EndoBarrier Duodenal-Jejunal Bypass Liner: A Novel Endoscopic Adjunct for Improved Glycemic Control and Weight Loss in Type 2 Diabetes with Obesity
Diabetes & EndocrinologyEndoBarrierEndoscopic Therapy

EndoBarrier Duodenal-Jejunal Bypass Liner: A Novel Endoscopic Adjunct for Improved Glycemic Control and Weight Loss in Type 2 Diabetes with Obesity

By MedXY|Jul 15, 2026

The ENDO trial demonstrates that the EndoBarrier duodenal-jejunal bypass liner significantly improves glycemic control and induces meaningful weight loss in patients with poorly controlled type 2 diabetes and obesity, with an acceptable saf

Reclassifying Pediatric NAFLD: Insights from the Steatotic Liver Disease Framework in a Multicenter NASH CRN Study
Gastroenterologydrug-induced liver injuryMASLD

Reclassifying Pediatric NAFLD: Insights from the Steatotic Liver Disease Framework in a Multicenter NASH CRN Study

By MedXY|Jul 15, 2026

A multicenter study reclassifies pediatric NAFLD under the steatotic liver disease framework, revealing most children meet MASLD criteria, while highlighting alcohol and medication-related reclassifications that inform diagnosis and managem

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen
Gastroenterologychronic hepatitis BHBsAg seroclearance

Long-term Risk of Hepatocellular Carcinoma After Clearance of Hepatitis B Surface Antigen

By MedXY|Jul 14, 2026

This study evaluates the long-term incidence of liver cancer in chronic hepatitis B patients who clear hepatitis B surface antigen, finding significantly reduced cancer risk in younger patients without cirrhosis.

Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis Mechanism
CardiologyBisphenol Fcardiomyopathy

Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis Mechanism

By MedXY|Jul 14, 2026

This study reveals that bisphenol F exposure aggravates cardiomyopathy under hemodynamic stress through gut microbiota metabolism, highlighting a novel gut-heart axis involving N-acetylputrescine and potential therapeutic targets.

Optimizing Prognostic Accuracy in Duodenal Adenocarcinoma: Evaluating Lymph Node Staging Schemes and a Novel Nomogram
Gastroenterologyduodenal adenocarcinomalog odds of positive lymph nodes

Optimizing Prognostic Accuracy in Duodenal Adenocarcinoma: Evaluating Lymph Node Staging Schemes and a Novel Nomogram

By MedXY|Jul 13, 2026

This study identifies log odds of positive lymph nodes as the superior prognostic parameter in duodenal adenocarcinoma and introduces a validated nomogram that integrates this metric with clinical factors to improve individualized survival

Serum Bile Acid Levels as Early Predictors of Portal Hypertension and Esophageal Varices Post-Kasai in Biliary Atresia
GastroenterologyBiliary AtresiaEsophageal Varices

Serum Bile Acid Levels as Early Predictors of Portal Hypertension and Esophageal Varices Post-Kasai in Biliary Atresia

By MedXY|Jul 13, 2026

Serum bile acid levels measured within the first year after Kasai procedure accurately predict portal hypertension and high-risk esophageal varices development within five years in biliary atresia patients, offering a valuable non-invasive

Unraveling IBS Genetics: Insights into Cardiometabolic and Triglyceride-Linked Mechanisms from a Large GWAS Meta-Analysis
GastroenterologyCardiometabolicgenetic risk

Unraveling IBS Genetics: Insights into Cardiometabolic and Triglyceride-Linked Mechanisms from a Large GWAS Meta-Analysis

By MedXY|Jul 13, 2026

A genome-wide meta-analysis of 2.8 million individuals reveals genetic links between irritable bowel syndrome, brain-gut pathways, and cardiometabolic traits, highlighting novel therapeutic targets involving triglyceride metabolism.

Evaluating Dose Intensification Strategies for Ustekinumab in Crohn’s Disease: Insights from the REScUE Trial
Gastroenterologyclinical trialCrohn’s disease

Evaluating Dose Intensification Strategies for Ustekinumab in Crohn’s Disease: Insights from the REScUE Trial

By MedXY|Jul 13, 2026

The REScUE study compared two ustekinumab dosing intensification regimens after secondary loss of response in Crohn’s disease, finding no superiority of more frequent dosing regarding steroid-free remission at 48 weeks.

Durvalumab Plus Chemotherapy Extends Survival in Advanced Biliary Tract Cancer: Insights from the TOPAZ-1 Trial Four-Year Post Hoc Analysis
GastroenterologyBiliary tract cancercisplatin

Durvalumab Plus Chemotherapy Extends Survival in Advanced Biliary Tract Cancer: Insights from the TOPAZ-1 Trial Four-Year Post Hoc Analysis

By MedXY|Jul 12, 2026

A four-year post hoc analysis of the TOPAZ-1 trial confirms that durvalumab combined with gemcitabine and cisplatin offers a long-term survival benefit with manageable safety as first-line treatment for advanced biliary tract cancer.

Sustained Quality of Life After Pancreatic Surgery for IPMNs in Young Patients: Long-Term Data and Clinical Implications
GastroenterologyIPMNPhẫu thuật gan tụy

Sustained Quality of Life After Pancreatic Surgery for IPMNs in Young Patients: Long-Term Data and Clinical Implications

By MedXY|Jul 11, 2026

Young patients undergoing resection for intraductal papillary mucinous neoplasms (IPMNs) exhibit excellent long-term quality of life comparable to the general population despite endocrine and exocrine insufficiencies.

Refining Pancreatic Cystic Neoplasm Assessment: The Incremental Role of Endoscopic Ultrasound and Fine Needle Aspiration
GastroenterologyDiagnostic accuracyendoscopic ultrasound

Refining Pancreatic Cystic Neoplasm Assessment: The Incremental Role of Endoscopic Ultrasound and Fine Needle Aspiration

By MedXY|Jul 11, 2026

This study evaluates the added value of endoscopic ultrasound (EUS) and fine needle aspiration (FNA) after MRI in assessing pancreatic cystic neoplasms, demonstrating significant improvement in diagnostic specificity and clinical decision-m

Unraveling Hepatitis B-Induced Liver Fibrosis: The Critical Role of Pyruvate, PPARα, and Reactive Oxygen Species
GastroenterologyHBVliver fibrosis

Unraveling Hepatitis B-Induced Liver Fibrosis: The Critical Role of Pyruvate, PPARα, and Reactive Oxygen Species

By MedXY|Jul 10, 2026

This article explores the mechanism by which HBV induces liver fibrosis through pyruvate-dependent ROS production and PPARα inhibition, highlighting novel therapeutic targets for chronic hepatitis B management.

Unveiling the Role of IL-10-Neutralising Autoantibodies in Pediatric-Onset Inflammatory Bowel Disease: Prevalence, Persistence, and Clinical Implications
Gastroenterologyhematopoietic stem-cell transplantationIL-10 autoantibodies

Unveiling the Role of IL-10-Neutralising Autoantibodies in Pediatric-Onset Inflammatory Bowel Disease: Prevalence, Persistence, and Clinical Implications

By MedXY|Jul 10, 2026

This study reveals that IL-10-neutralising autoantibodies occur in 2.1% of pediatric IBD cases without monogenic causes, persist over years, and may define a distinct clinical subgroup with specific therapeutic needs.

Prev
7 / 25
1…56789…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles